BNBionano Genomics, Inc. BNGO · NASDAQ
$1.22 +5.17% (+$0.06)
- Market cap
- $14.4M
- Enterprise value
- $17.3M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 0.5x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -83.9%
- Bruto marža
- 47.5%
- Neto marža
- -106.6%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 1.66
- Free float
- 90.3%
O podjetju
Bionano Genomics (BNGO) is a biotechnology company focused on developing and commercializing its advanced genomic platform. This platform enables the study of the structure and variations of the human genome with high accuracy and detail. Bionano Genomics aims to provide tools for genetic research, genetic disease diagnostics, and personalized medicine. Bionano Genomics stock is suitable for investors interested in the biotechnology sector and innovative technologies in the field of genetics. Add Bionano Genomics stock to your watchlist on Bulios and stay informed about the latest advancements in genomics and biotechnology.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert A. Luderer
Employees
96
Headquarters
San Diego
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
- Na kaj bodite pozorni: Rast prihodkov se upočasnjuje: 0,8 % letno v zadnjih 3 letih proti 27 % v 5 letih.
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
- Na kaj bodite pozorni: Podjetje je v zadnjih 12 mesecih poslovalo z izgubo.
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke